DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 122 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$32,187,000
-41.1%
2,299,046
-32.9%
1.24%
-44.8%
Q4 2016$54,624,000
-4.5%
3,424,676
-0.3%
2.25%
-15.5%
Q3 2016$57,168,000
-14.8%
3,435,576
-42.7%
2.66%
+0.8%
Q2 2016$67,103,000
+33.9%
5,996,6910.0%2.64%
+23.6%
Q1 2016$50,132,000
-10.2%
5,996,6910.0%2.13%
-5.7%
Q4 2015$55,829,000
+3.5%
5,996,691
+25.3%
2.26%
+8.4%
Q3 2015$53,965,000
-11.1%
4,784,1570.0%2.09%
+3.2%
Q2 2015$60,711,000
+57.9%
4,784,157
+15.7%
2.02%
+62.5%
Q1 2015$38,448,000
-35.1%
4,134,157
-0.1%
1.24%
-41.5%
Q4 2014$59,282,000
+163.3%
4,139,787
+90.9%
2.13%
+159.4%
Q3 2014$22,511,000
+28.2%
2,168,675
+99.8%
0.82%
+16.3%
Q2 2014$17,560,000
+115.4%
1,085,301
+116.3%
0.71%
+112.0%
Q1 2014$8,153,000
+4.1%
501,709
-20.5%
0.33%
-18.0%
Q4 2013$7,834,000
-12.8%
631,276
-23.0%
0.41%
-2.9%
Q3 2013$8,979,000820,0000.42%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,658,759$121,733,0008.95%
Palo Alto Investors LP 4,155,670$108,588,0005.78%
Stonepine Capital Management, LLC 220,848$5,771,0005.07%
Birchview Capital, LP 80,000$2,090,0001.98%
EAM Global Investors LLC 75,310$1,968,0001.08%
Atika Capital Management LLC 130,000$3,397,0001.00%
EAM Investors, LLC 110,806$2,895,0000.79%
UNIVERSITY OF NOTRE DAME DU LAC 97,521$2,548,0000.62%
ALGERT GLOBAL LLC 76,204$1,991,0000.56%
361 CAPITAL LLC 85,885$2,244,0000.46%
View complete list of VANDA PHARMACEUTICALS INC shareholders